104 related articles for article (PubMed ID: 16563274)
1. [Atorvastatin upregulates the expression of PPAR alpha/gamma and inhibits the hypertrophy of cardiac myocytes in vitro].
Sheng L; Ye P; Liu YX
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1080-4. PubMed ID: 16563274
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin attenuating down-regulation of peroxisome proliferator-activated receptor gamma in preventing cardiac hypertrophy of rats in vitro and in vivo.
Ye P; Sheng L; Zhang C; Liu Y
J Pharm Pharm Sci; 2006; 9(3):365-75. PubMed ID: 17207419
[TBL] [Abstract][Full Text] [Related]
4. Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor Beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro.
Sheng L; Yang X; Ye P; Liu YX; Han CG
Chin Med Sci J; 2015 Dec; 30(4):245-51. PubMed ID: 26960306
[TBL] [Abstract][Full Text] [Related]
5. [Atorvastatin attenuates parathyroid hormone 1-34 induced cardiomyocytes hypertrophy through downregulating K-Ras-ERK1/2 pathway].
Liu XG; Miao N; Sui MS; Mu SH; Zhao SL; Xie RJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1051-5. PubMed ID: 23363723
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
[TBL] [Abstract][Full Text] [Related]
7. [The effect of PPARalpha signal channel on atorvastatin inhibiting MMP-9 expression in aging myocytes].
Han L; Ye P; Li MG
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):469-72. PubMed ID: 24386831
[TBL] [Abstract][Full Text] [Related]
8. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
Ye P; Yang W; Wu SM; Sheng L
Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro protective effects of pentamethylquercetin on cardiac hypertrophy.
He T; Chen L; Chen Y; Han Y; Yang WQ; Jin MW
Cardiovasc Drugs Ther; 2012 Apr; 26(2):109-20. PubMed ID: 22183794
[TBL] [Abstract][Full Text] [Related]
10. Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity.
Yan L; Zhang JD; Wang B; Lv YJ; Jiang H; Liu GL; Qiao Y; Ren M; Guo XF
PLoS One; 2013; 8(9):e72548. PubMed ID: 24039778
[TBL] [Abstract][Full Text] [Related]
11. [Pioglitazone inhibits cardiac hypertrophy of rats in vitro and in vivo].
Ye P; Zhang C; Wu SM; Liu YX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Feb; 21(1):35-9. PubMed ID: 21166160
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation.
Planavila A; Laguna JC; Vázquez-Carrera M
Biochim Biophys Acta; 2005 Feb; 1687(1-3):76-83. PubMed ID: 15708355
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells.
Planavila A; Sánchez RM; Merlos M; Laguna JC; Vázquez-Carrera M
Biochim Biophys Acta; 2005 Sep; 1736(2):120-7. PubMed ID: 16139565
[TBL] [Abstract][Full Text] [Related]
15. In vitro modulation of peroxisome proliferator-activated receptor-gamma and its genes by C-reactive protein. Role of atorvastatin.
Mahajan N; Dhawan V
Arch Med Res; 2010 Apr; 41(3):154-61. PubMed ID: 20682172
[TBL] [Abstract][Full Text] [Related]
16. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
17. [The effect of relgulation of PPAR-α on cardiac hypertrophy and the relationship between the effect of PPAR-α with PI3K/Akt/mTOR pathway].
Wu Y; Wang BX; Guo YY; Wang YQ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):284-8. PubMed ID: 26387199
[TBL] [Abstract][Full Text] [Related]
18. Use of atorvastatin to inhibit hypoxia-induced myocardin expression.
Chiu CZ; Wang BW; Shyu KG
Eur J Clin Invest; 2012 May; 42(5):564-71. PubMed ID: 22129233
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.
Sanguino E; Roglans N; Alegret M; Sánchez RM; Vázquez-Carrera M; Laguna JC
Br J Pharmacol; 2005 Aug; 145(7):853-61. PubMed ID: 15912134
[TBL] [Abstract][Full Text] [Related]
20. Apigenin-induced HIF-1α inhibitory effect improves abnormal glucolipid metabolism in AngⅡ/hypoxia-stimulated or HIF-1α-overexpressed H9c2 cells.
Zhu ZY; Wang F; Jia CH; Xie ML
Phytomedicine; 2019 Sep; 62():152713. PubMed ID: 31078968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
